Hepatitis B virus (HBV) infection is a worldwide health problem. The prevalence of HBV carriers varies from 0.1 to 2% in low prevalent areas to 10 to 20% in high prevalent areas. Indonesia is among the HBV high prevalent countries (16). The identification of the common determinant a and two pairs of allelic variations, d/y and w/r, has lead to the definition of the four major subtypes of hepatitis B surface antigen (HBsAg), adw, adr, ayw, and ayr (3,13,18,37). Another classification system, which is based on the sequence diversity of the HBV genome has been developed and, currently eight genotypes designated A to H have been identified (1,4,23,25,35). It has been reported that distribution of HBV subtypes and genotypes varies with different geographical areas (2,15,18,22,24,26). Also, clinical manifestations and therapeutic responses to antiviral therapy might differ with different HBV genotypes (11,12,39 Abstract: Four subtypes (adw, adr, ayw, and ayr) and eight genotypes (A to H) of the hepatitis B virus (HBV) have been identified. They appear to be associated with particular geographic distribution, ethnicity, and possibly clinical outcomes. In this study, hepatitis B surface antigen (HBsAg) subtyping and HBV genotyping were carried out on sera obtained from HBsAg-positive HBV carriers, including healthy blood donors; patients with acute hepatitis, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma; and patients on hemodialysis all located in Surabaya, Indonesia. We report here that all HBV isolates tested in Surabaya belonged to genotype B, with more than 90% of them being classified into subtype adw. Our results also revealed that prevalence of hepatitis C virus (HCV) co-infection among HBV carriers in Surabaya was approximately 10% for healthy blood donors and patients with chronic liver disease, and approximately 60% for patients on maintenance hemodialysis. Interestingly, HBsAg titers were lower in HBV carriers with HCV co-infection than in those without HCV co-infection. We also found that prevalence of hepatitis D virus (HDV) co-infection was <0.5% among HBV carriers in Surabaya.